Sichuan Kelun Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,259.20",
          "val2": "4,389.90",
          "chgp": "-2.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "267.10",
          "val2": "1,012.40",
          "chgp": "-73.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "23.10",
          "val2": "26.50",
          "chgp": "-12.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.20",
          "val2": "7.60",
          "chgp": "-5.26%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "472.70",
          "val2": "659.60",
          "chgp": "-28.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "62.70%",
          "val2": "150.30%",
          "chgp": "-8.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -15.12% vs 1.69% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -44.16% vs 27.03% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "18,350.10",
          "val2": "21,619.40",
          "chgp": "-15.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,433.70",
          "val2": "5,141.30",
          "chgp": "-33.21%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "107.40",
          "val2": "154.70",
          "chgp": "-30.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "49.90",
          "val2": "-24.50",
          "chgp": "303.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,877.20",
          "val2": "3,362.00",
          "chgp": "-44.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "109.70%",
          "val2": "177.80%",
          "chgp": "-6.81%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

4,259.20

4,389.90

-2.98%

Operating Profit (PBDIT) excl Other Income

267.10

1,012.40

-73.62%

Interest

23.10

26.50

-12.83%

Exceptional Items

7.20

7.60

-5.26%

Consolidate Net Profit

472.70

659.60

-28.34%

Operating Profit Margin (Excl OI)

62.70%

150.30%

-8.76%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -2.98% vs -29.42% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -28.34% vs -48.70% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

18,350.10

21,619.40

-15.12%

Operating Profit (PBDIT) excl Other Income

3,433.70

5,141.30

-33.21%

Interest

107.40

154.70

-30.58%

Exceptional Items

49.90

-24.50

303.67%

Consolidate Net Profit

1,877.20

3,362.00

-44.16%

Operating Profit Margin (Excl OI)

109.70%

177.80%

-6.81%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -15.12% vs 1.69% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -44.16% vs 27.03% in Dec 2024

All Annual Results